<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Childhood arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> treatment guidelines recommend extended anticoagulation in cardioembolism and dissection </plain></SENT>
<SENT sid="1" pm="."><plain>We sought to investigate the safety of extended anticoagulation in childhood arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> with nonmoyamoya <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">arteriopathy</z:e>, for which the risk of recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> is high </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Thirty-seven patients with <z:hpo ids='HP_0011463'>childhood-onset</z:hpo> arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">arteriopathy</z:e> (excluding <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e>) were diagnosed between 1999 and 2007 and treated with anticoagulation for at least 4 weeks </plain></SENT>
<SENT sid="3" pm="."><plain>Patients were followed in hospital-based cohort studies at 2 centers and systematically assessed for <z:mp ids='MP_0001914'>bleeding</z:mp> episodes and recurrent events </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Over a cumulative anticoagulation duration of 1329 patient-months, there were no major <z:mp ids='MP_0001914'>bleeding</z:mp> episodes and 2 clinically relevant <z:mp ids='MP_0001914'>bleeding</z:mp> episodes </plain></SENT>
<SENT sid="5" pm="."><plain>Cumulative probability of recurrent arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> at 1 year was 14% </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Anticoagulation can be used safely for secondary arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> prevention in children with <z:hpo ids='HP_0011009'>acute</z:hpo> nonmoyamoya <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">arteriopathy</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Anticoagulation is worthy of evaluation in future randomized, controlled treatment trials in this disease </plain></SENT>
</text></document>